Accretion/Dilution
Executive Summary
Key Takeaways
- ✓ Accretion/dilution analysis compares an acquirer's pro-forma earnings per share against its standalone EPS to determine whether a proposed acquisition would increase (accretive) or decrease (dilutive) the acquirer's EPS.
- ✓ The result depends on both the combined entity's pro-forma net income and the pro-forma diluted share count, each of which is affected by the deal's financing structure — cash, debt, or newly issued stock.
- ✓ A useful rule of thumb is that a stock-funded deal is typically accretive if the acquirer's P/E multiple is higher than the target's (and dilutive if lower), though this shortcut ignores synergies and incremental purchase-price-allocation D&A, and should never replace the full calculation.
- ✓ Accretion/dilution measures a deal's near-term EPS effect, a financing and structuring question, not whether the acquirer is paying a fair price for the target, which is a separate valuation question.
Definition¶
Accretion/dilution analysis compares an acquirer's pro-forma (post-transaction, combined) earnings per share against its standalone (pre-transaction) earnings per share, to determine whether a proposed acquisition would increase or decrease the acquirer's EPS. It is the headline quantitative output of a merger model.
The Calculation¶
Pro-Forma EPS = (Acquirer Standalone Net Income + Target Standalone Net Income
+ After-Tax Synergies − After-Tax Incremental Interest Expense
− Incremental D&A from Purchase Price Allocation)
÷ Pro-Forma Diluted Share Count
Accretion / (Dilution) % = (Pro-Forma EPS ÷ Acquirer Standalone EPS) − 1
A positive result means the deal is accretive — pro-forma EPS exceeds the acquirer's standalone EPS. A negative result means the deal is dilutive — pro-forma EPS falls short of standalone EPS. Both the numerator (pro-forma net income, affected by synergies and incremental D&A from purchase price allocation) and the denominator (diluted share count, affected by whether the deal is stock-funded) are driven directly by the deal's structure, which is why the full build sequence described on the Merger Model and Accretion/Dilution Structure guide matters to arriving at a reliable result.
The P/E Rule of Thumb¶
A commonly used directional shortcut: a stock-funded acquisition is typically accretive to the acquirer if the acquirer's own P/E multiple is higher than the effective P/E implied by the price paid for the target, and dilutive if the acquirer's P/E is lower. The underlying intuition is that a higher-multiple acquirer effectively "buys" the target's earnings more cheaply, in relative multiple terms, than the market values its own earnings.
This rule of thumb is a useful sanity check but ignores synergies and the incremental depreciation and amortization arising from purchase price allocation, both of which can meaningfully move the actual result. It should never substitute for the full calculation in an actual deal model — it is a directional check on a completed calculation, not a replacement for one.
Accretion/Dilution Is Not a Valuation Verdict¶
Accretion/dilution measures a deal's near-term effect on the acquirer's earnings per share — a financing and structuring outcome, not a judgment on whether the acquirer is paying a fair price for the target. A deal can be accretive and still overpriced relative to the target's underlying value; a deal can be dilutive in the near term and still be a sound strategic and financial decision over a longer horizon, particularly where the target requires an initial integration period before its full earnings potential is realized. Whether the price paid is fair is a separate question, addressed through the target's own standalone valuation — see the Discounted Cash Flow (DCF) Valuation pillar.
Continue Reading¶
Related Pillars¶
Related Technical Guides¶
Related Glossary¶
How OXXON tests thisRun a free structural check with FMAE
Frequently Asked Questions
What is accretion/dilution analysis?
A comparison of an acquirer's pro-forma (post-transaction, combined) earnings per share against its standalone (pre-transaction) earnings per share, used to determine whether a proposed acquisition would increase (accretive) or decrease (dilutive) the acquirer's EPS — the headline output of a merger model.
What is the accretion/dilution formula?
Pro-Forma EPS = (Acquirer standalone net income + Target standalone net income + after-tax synergies − after-tax incremental interest expense − incremental D&A from purchase price allocation) ÷ pro-forma diluted share count. Accretion/(Dilution) % = (Pro-Forma EPS ÷ Acquirer Standalone EPS) − 1. A positive result is accretive; a negative result is dilutive.
What is the P/E rule of thumb for accretion/dilution in a stock-funded deal?
A stock-funded deal is typically accretive to the acquirer if the acquirer's P/E multiple is higher than the price paid for the target (implying the target's effective P/E), and dilutive if the acquirer's P/E is lower. This is a useful directional shortcut but ignores synergies and incremental purchase-price-allocation D&A, and should never substitute for the full calculation in an actual deal model.
Does an accretive deal mean the acquirer is paying a fair price?
Not necessarily. Accretion/dilution measures the deal's near-term effect on the acquirer's earnings per share — a financing and structuring question. Whether the acquirer is paying a fair price for the target is a separate valuation question, independently assessed through the target's own DCF, comparable company analysis, or precedent transactions analysis.
Can a dilutive deal still be a good strategic decision?
Yes. A deal can be near-term dilutive to EPS while still being strategically and financially sound over a longer horizon — for example, where the target requires an initial integration or investment period before its full earnings potential is realized, or where the strategic rationale (market access, technology acquisition) is not primarily an EPS-accretion argument in the first place.
Related Articles
Corporate Financial Modelling
Corporate financial modelling is the discipline of building financial models for operating companies — as distinct from a single asset, project, or development. Nearly every corporate model type is built on the same foundation, a fully integrated three-statement structure, and then specializes that foundation toward a specific purpose: a budget model constrains it to a fixed annual period, a driver-based model rebuilds it from operational units rather than percentage growth, a consolidation model extends it across multiple legal entities and currencies, a management reporting model extracts and re-presents its outputs as KPIs, and a transaction model (a merger model, an LBO) repurposes it to answer a specific capital-structure or ownership-change question. This page is the hub for the Knowledge Centre's corporate financial modelling content: the shared three-statement foundation, how each model type specializes it, and where each mechanic is covered in full technical depth elsewhere on this platform.
Merger Model and Accretion/Dilution Structure
A merger model tests whether a proposed acquisition increases or decreases the acquirer's earnings per share — the accretion/dilution result — by combining standalone projections for the acquirer and target with the mechanics specific to the transaction itself: purchase price allocation and the resulting goodwill, the financing structure (cash, new debt, or newly issued stock, in any combination), and any synergies expected from the combination. This guide covers the build sequence in full: standalone projections first, then purchase price allocation, then the financing structure and its effect on pro-forma shares and interest expense, then synergies traced to specific line items rather than a single aggregate assumption, and finally the accretion/dilution calculation itself, with the structural checks that catch the errors most specific to this model type.
Purchase Price Allocation
Purchase price allocation (PPA) is the process, required under both IFRS and US GAAP acquisition accounting, of allocating the price paid for an acquired business between its identifiable net assets, recorded at fair value as of the acquisition date, and goodwill, the residual representing value the acquirer paid beyond those identifiable assets. The allocation directly determines the combined entity's post-transaction depreciation and amortization, since revalued tangible assets and newly recognized intangible assets each carry their own schedule going forward, distinct from goodwill, which is not amortized but is tested periodically for impairment.
Synergies
Synergies are the cost savings or revenue benefits a combined entity is expected to achieve that neither the acquirer nor the target could achieve standalone — eliminating a duplicated corporate function, negotiating better procurement terms at greater combined scale, or cross-selling one company's products through the other's customer base. In a merger model, synergies should be traced to specific, named drivers and phased in over a stated, realistic timeline rather than entered as a single aggregate addition to combined EBITDA, since an untraceable synergy figure is one of the most common ways a deal's headline accretion is overstated.
Diluted Share Count
Diluted share count is the number of shares used as the divisor when converting total equity value into value per share, and it differs from basic shares outstanding by including the potential dilutive effect of options, warrants, convertible debt, and convertible preferred stock. Options and warrants are incorporated using the treasury stock method; convertible securities are incorporated using the if-converted method, which also requires adding back the interest or dividend the company would no longer pay if conversion occurred. Using the correct diluted share count is the final step in a DCF's enterprise-to-equity value bridge, and understating dilution is a common source of overstated value per share.
IRR (Internal Rate of Return)
Internal Rate of Return (IRR) is the discount rate at which the net present value of a series of cash flows equals zero. It is the generic form of a metric that appears in financial models in several more specific variants, most commonly Project IRR and Equity IRR, each defined on its own cash flow basis. This page defines the generic IRR concept and the Excel functions used to calculate it; for the project finance-specific variants, see Project IRR and Equity IRR.